About Medech
Broker Overview
Medech is a forex and CFD broker registered in the United Kingdom, founded on 10 November 2020. The broker operates under the domain medech.co and targets high-net-worth individuals with its tiered account structure. According to our records, Medech does not hold any regulatory licences from recognised financial authorities, which is a significant factor for traders to consider.
Account Types and Minimum Deposits
Medech offers four account tiers: Bronze, Silver, Gold, and Black. The Bronze account requires a minimum deposit of €10,000, while the Silver, Gold, and Black accounts require €20,000, €50,000, and €100,000 respectively. These high entry thresholds suggest the broker is aiming at experienced or affluent traders. The accounts are named to imply a progressive service level, though specific benefits beyond leverage are not detailed in our available data.
Leverage Offered
Leverage varies by account tier: Bronze offers up to 1:100, Silver up to 1:200, Gold up to 1:300, and Black up to 1:500. These levels indicate a focus on high-risk, high-reward trading. Without regulatory oversight, such high leverage amplifies both potential profits and losses, requiring traders to exercise strong risk management.
Regulatory Status
As of our review, Medech has no listed regulators. The absence of regulatory supervision is a critical point, as it means the broker is not subject to standard financial conduct rules, client fund segregation requirements, or dispute resolution mechanisms. Traders should be aware that this lack of oversight increases counterparty risk.
Transparency and Public Information
Independent public information about Medech is limited. Our web search results returned information for a different entity, and no official website content was available for analysis. This lack of transparency makes it difficult to verify the broker's claims about its services, execution, or client protection measures.
Target Audience
Given the high minimum deposits and high leverage options, Medech appears to target high-net-worth individuals and professional traders. The tiered structure suggests an attempt to cater to different levels of capital, but the lack of regulatory safeguards and public reviews means this audience must proceed with caution.
Overview compiled by FXCanary from regulatory records and public data. full Medech review